There were no significant differences between the cTACE and non-cTACE groups with respect to gender, age, etiology (HBV or HCV/NBNC), Child-Pugh score (5 or 6/7 or 8), clinical stage (II or III/IVA or IVB), tumor number (<4/4≤), maximum tumor size, MC (SN or SNE/CMN), up-to-7 criteria (IN/OUT), AFP, AFP-L3, or DCP. This evidence concerns the gene AFP and neoplasm.